title: Body weight gain induced by a newer antipsychotic agent reversed as negative symptoms improved.
abstract: OBJECTIVE
  We describe a patient in whom improvement in negative symptoms contributed to early weight loss and subsequent long-term improvement in weight management.
  
  
  METHODS
  Case report.
  
  
  RESULTS
  A 26-year-old woman with schizophrenia gained 7 kg over the course of 1 year after starting treatment with olanzapine. However, as negative symptoms gradually improved with treatment, she became motivated to diet and exercise regularly. She quickly lost 9 kg and subsequently maintained optimal weight (55 kg; body mass index, 24.1 kg/m(2) ).
  
  
  CONCLUSIONS
  Important strategies for minimizing weight gain in patients taking antipsychotic agents include improving negative symptoms of avolition and apathy, regular monitoring of body weight and potential medical consequences of overweight and obesity, and educating the patient about the importance of diet and regular exercise.
authors.affiliation: Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan. mi-na@pd5.so-net.ne.jp
authors.forename: M
authors.initials: M
authors.lastname: Koga
authors.forename: K
authors.initials: K
authors.lastname: Nakayama
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D002746:Chlorpromazine / Q000009:adverse effects* / Q000627:therapeutic use; D004032:Diet; D015444:Exercise; D005260:Female; D006220:Haloperidol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D000077152:Olanzapine; D012559:Schizophrenia / Q000188:drug therapy*; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D006220:Haloperidol; D000077152:Olanzapine; D002746:Chlorpromazine